billHR9104•Event Tuesday, June 2, 2026Analyzed

Rock Creek National Park Act of 2026

Neutral

Summary

HR9104 is a purely symbolic redesignation bill that authorizes zero dollars and imposes zero regulatory changes. It is in the earliest legislative stage with zero momentum. There is no measurable market impact for any public company.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR9104 authorizes $0 and has zero fiscal impact on any sector or company.
  • 2.The bill is at the earliest stage with no cosponsors, no companion bill, and a non-voting sponsor — negligible passage probability.
  • 3.No publicly traded company has any measurable exposure to this purely symbolic name change.

Market Implications

None. This is a procedural naming bill with no financial mechanism. Investors should ignore it entirely.

Full Analysis

  1. WHAT HAPPENED: On June 2, 2026, Del. Norton (D-DC) introduced HR9104 to rename Rock Creek Park in Washington, D.C. as 'Rock Creek National Park'. The bill was immediately referred to the House Natural Resources Committee. It remains in early stage with no hearings, no companion Senate bill, and no cosponsors.

  2. MONEY TRAIL: The bill authorizes $0. It appropriates $0. It imposes no tax credits, no penalties, no new fees, and no spending mandates. This is a pure naming act with zero fiscal impact. The National Park Service's existing budget for Rock Creek Park is unchanged.

  3. STRUCTURAL WINNERS AND LOSERS: There are no winners or losers. No company's revenue, costs, or competitive position is affected by this bill. The only conceivable tie to any public company would be concessionaires operating within the park, but Rock Creek Park is a small urban park with minimal commercial concessions — no publicly traded company has material exposure.

  4. TIMELINE: The bill has cleared no procedural hurdles. It must pass the House Natural Resources Committee, then the full House, then the Senate, then be signed by the President. With a single sponsor (a non-voting delegate), no cosponsors, and zero committee action, passage probability in the 119th Congress is negligible.

Key Legislators

Del. Norton, Eleanor Holmes [D-DC-At Large]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationOct 23, 2026

FURTHER MODIFYING THE SCOPE OF PRODUCTS OF CANADA SUBJECT TO THE ADDITIONAL DUTIES IMPOSED TO OFFSET CANADIAN DISCRIMINATION AGAINST THE COMMERCE OF THE UNITED STATES WITH RESPECT TO MOTOR VEHICLES

This proclamation modifies the list of Canadian products subject to a 50% additional ad valorem duty imposed under Section 338 of the Tariff Act of 1930, removing some products from the duty and adding others, effective October 30, 2026. The action is part of an ongoing dispute over Canada's motor vehicle tariff scheme and is intended to offset discrimination against U.S. commerce. The President directs implementation through the Harmonized Tariff Schedule and authorizes U.S. Customs and Border Protection to issue rules.

Exec OrderOct 22, 2026

DECREASING HOUSING COSTS FOR THE AMERICAN PEOPLE

This executive order directs the Federal Housing Finance Agency to create pilot programs for automatic cancellation of mortgage insurance when borrowers have sufficient equity, and to expand a title insurance pilot to reduce costs for refinancing. It establishes a task force to promote manufactured housing by standardizing permits and reducing regulatory barriers. It also orders the Departments of Agriculture and Veterans Affairs to reduce interest rates on direct home loans.

Exec OrderOct 19, 2026

Advancing Women's Health to Improve Outcomes in All Phases of Life

This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →